MGRO π MustGrow Biologics - Overview
Exchange: V • Country: Canada • Currency: CAD • Type: Common Stock •
MGRO: Biopesticides, Biofertilizers, Soil Amendments, Biocontrols
MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. The company also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, it is developing TerraSante, an organic soil amendment and biofertility technology. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada. Web URL: https://mustgrow.ca
Additional Sources for MGRO Stock
MGRO Stock Overview
Market Cap in USD | 54m |
Sector | Basic Materials |
Industry | Agricultural Inputs |
GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
IPO / Inception |
MGRO Stock Ratings
Growth 5y | 35.4% |
Fundamental | -23.0% |
Dividend | - |
Rel. Strength Industry | -2220 |
Analysts | - |
Fair Price Momentum | 1.14 CAD |
Fair Price DCF | 0.86 CAD |
MGRO Dividends
No Dividends PaidMGRO Growth Ratios
Growth Correlation 3m | 29.6% |
Growth Correlation 12m | 3.6% |
Growth Correlation 5y | 17.9% |
CAGR 5y | 17.27% |
CAGR/Mean DD 5y | 0.36 |
Sharpe Ratio 12m | 0.22 |
Alpha | -25.02 |
Beta | 0.67 |
Volatility | 82.45% |
Current Volume | 10.9k |
Average Volume 20d | 14.5k |
What is the price of MGRO stocks?
As of December 22, 2024, the stock is trading at CAD 1.22 with a total of 10,910 shares traded.
Over the past week, the price has changed by -16.55%, over one month by -35.29%, over three months by +15.24% and over the past year by -3.20%.
As of December 22, 2024, the stock is trading at CAD 1.22 with a total of 10,910 shares traded.
Over the past week, the price has changed by -16.55%, over one month by -35.29%, over three months by +15.24% and over the past year by -3.20%.
Is MustGrow Biologics a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, MustGrow Biologics is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -22.96 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MGRO as of December 2024 is 1.14. This means that MGRO is currently overvalued and has a potential downside of -6.56%.
Neither. Based on ValueRay Fundamental Analyses, MustGrow Biologics is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -22.96 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MGRO as of December 2024 is 1.14. This means that MGRO is currently overvalued and has a potential downside of -6.56%.
Is MGRO a buy, sell or hold?
MustGrow Biologics has no consensus analysts rating.
MustGrow Biologics has no consensus analysts rating.
What are the forecast for MGRO stock price target?
According to ValueRays Forecast Model, MGRO MustGrow Biologics will be worth about 1.3 in December 2025. The stock is currently trading at 1.22. This means that the stock has a potential upside of +2.46%.
According to ValueRays Forecast Model, MGRO MustGrow Biologics will be worth about 1.3 in December 2025. The stock is currently trading at 1.22. This means that the stock has a potential upside of +2.46%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 1.3 | 2.5% |